Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jun;117(6):1289-1297.
doi: 10.1097/AOG.0b013e31821b5118.

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors

Frederick R Ueland  1 , Christopher P Desimone, Leigh G Seamon, Rachel A Miller, Scott Goodrich, Iwona Podzielinski, Lori Sokoll, Alan Smith, John R van Nagell Jr, Zhen Zhang
Affiliations
Clinical Trial

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors

Frederick R Ueland et al. Obstet Gynecol. 2011 Jun.

Abstract

Objective: To compare the effectiveness of physician assessment with a new multivariate index assay in identifying high-risk ovarian tumors.

Methods: The multivariate index assay was evaluated in women scheduled for surgery for an ovarian tumor in a prospective, multi-institutional trial involving 27 primary- care and specialty sites throughout the United States. Preoperative serum was collected, and results for the multivariate index assay, physician assessment, and CA 125 were correlated with surgical pathology. Physician assessment was documented by each physician before surgery. CA 125 cutoffs were chosen in accordance with the referral guidelines of the American College of Obstetricians and Gynecologists.

Results: The study enrolled 590 women, with 524 evaluable for the multivariate index assay and CA 125, and 516 for physician assessment. Fifty-three percent were enrolled by nongynecologic oncologists. There were 161 malignancies and 363 benign ovarian tumors. Physician assessment plus the multivariate index assay correctly identified malignancies missed by physician assessment in 70% of nongynecologic oncologists, and 95% of gynecologic oncologists. The multivariate index assay also detected 76% of malignancies missed by CA 125. Physician assessment plus the multivariate index assay identified 86% of malignancies missed by CA 125, including all advanced cancers. The performance of the multivariate index assay was consistent in early- and late-stage cancers.

Conclusion: The multivariate index assay demonstrated higher sensitivity and lower specificity compared with physician assessment and CA 125 in detecting ovarian malignancies.

PubMed Disclaimer

References

    1. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 1995;273:491–7.
    1. Ozols RF. Update of the NCCN ovarian cancer practice guidelines. Oncology 1997;11:95–105.
    1. Le T, Giede C. Initial evaluation and referral guidelines for management of pelvic/ovarian masses. Joint SOGC/GOG/SCC Clinical Practice Guideline. Journal Obstet Gynaecol Can 2009;31:668–73.
    1. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. Obstet Gynecol 2002;100:1413–6.
    1. Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, et al. Management of adnexal mass. Rockville (MD): U.S. Department of Health and Human Services, 2006.

Publication types